US stock markets are set to open mixed as the post-Pfizer rally is reassessed, but cyclicals are still clearly outperforming the growth and momentum names that have notched the biggest gains during the pandemic.
AUD jumped after job data
Information is not investment advice
AUD approaches the strong resistance at 0.7185. What may happen next?
Today Australia reported that 114 700 its citizens found jobs in July. That numbers beat all estimates, as analysts anticipated only 30 000. Analysts may set such a low forecast because Australia was suffering from the fresh virus resurgence, especially its state Victoria. Australian unemployment rate exceeded expectations too: 7.5% vs predicted 7.8%.
As a result, the Australian dollar surged. Moreover, vaccine hopes and decreasing new virus cases improved the market sentiment and underpinned the risky aussie. Do you know that Australia is the second largest producer of gold after China? Last year Australia produced the record amount of yellow metal. Therefore, if the USD gets weaker and the gold price rises further, the AUD may become the best performer on the Forex market.
On the 4-hour chart we can see that AUD/USD bounced off the support line a 0.7115. It has broken out through the resistance at 0.7145 and two moving averages. The move above the high of August 11 at 0.7185 will drive the price to the high of August 7 at 0.7215. On the flip side, if it breaks down 0.7145, it may fall further to the support line at 0.7115.
Follow the speech of the governor of the Reserve Bank of Australia at 2.30 MT time on Friday! If the RBA’s tone is hawkish, the AUD will rise. Otherwise, if the RBA’s tone is dovish, the AUD will fall.
XAU/USD is eyeing $1 850. Will it be able to reach it?
Asia-Pacific stocks lacked firm direction as momentum faded from the record-setting performance on Wall St, where the S&P 500 and Nasdaq printed fresh all-time highs
Fed's Powell said a slowing recovery and a surging pandemic meant the US was entering a "challenging" few months, with the potential deployment of a vaccine still facing hurdles.